News and Trends 28 Aug 2015
FDA shelves UniQure’s Glybera – will the Gene therapy once reach the US market?
The €1.1M drug Glybera was the first gene therapy on the European market. UniQure wants to sell it in the US too, but the FDA makes it much more difficult than expected. UniQure’s financial report of the first half of 2015 shows good results, cash and cash equivalents of the company increased to €181.9M, compared with […]
